Reduced rates of acute kidney injury and chronic kidney disease
This effect likely combines direct medication effects with the consequences of reduced sodium intake and weight loss
Body Composition Benefits The type of weight lost matters as much as the amount
& Lu, J
Researchers and procurement buyers choose Aegis Peptides for: Clear product information Research-only positioning Supplier COA documentation where available Related Retatrutide product formats Free UK Tracked 24 delivery UK-focused online supply Straightforward product comparison Professional research-focused content Aegis Peptides does not provide medical advice, dosing advice, preparation instructions, administration guidance, injection guidance, treatment advice or personal-use support
2040 EORTC item Q168: the psychometric performance of a single-item indicator of side-effect burden for people with cancer Tamara Jones 1 , Florian Zeman 2 , Michael Koller 2 , Andreia Moura 3 , Claire Piccinin 3 , Sandra Nolte 1 1 Person-Centred Research, Eastern Health Clinical School, Monash University, Melbourne, Australia, 2 Center for Clinical Studies, University Hospital Regensburg, Regensburg, Germany, 3 Quality of Life Department, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :2040 Aims Following the release of the US Food and Drug Administration (FDA) Guidance on core patient-reported outcomes in cancer clinical trials, there has been growing interest in using single items to measure treatment tolerability from the patients perspective
